Yehuda Eliya serves as Executive at Raphael Pharmaceutical Inc., where they oversee executive responsibilities. Since joining the company, Yehuda Eliya has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Nov 25, 2023 involved receiving (via award) 150,000 shares valued at $60.0K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Nov 25, 2023 | RAPH | $60.0K | Award | 150,000 | $0.40 | Discretionary |
Yehuda Eliya currently holds 352,000 shares of Raphael Pharmaceutical Inc. (RAPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Yehuda Eliya has been a net neutral trader of RAPH stock. They have purchased $0 and sold $0 worth of shares.
Yehuda Eliya's most recent insider trade was on Nov 25, 2023, when they sold 150,000 shares at $0.40 per share.
Get notified when new Form 4 filings are submitted